To amend the Internal Revenue Code of 1986 to take certain Medicare premiums of household members into account in determining the health care insurance premiums tax credit.
Impact
If enacted, HB7017 would adjust tax responsibilities for specific taxpayers, potentially making healthcare more affordable for families with Medicare beneficiaries. This change could lower their overall effective tax burden and facilitate access to necessary medical insurance. The bill is set to take effect for coverage months beginning after December 31, 2024, which gives households time to adjust to the new provisions.
Summary
House Bill 7017 seeks to amend the Internal Revenue Code of 1986 by allowing household members' Medicare premiums to be considered when calculating eligibility for the health care insurance premiums tax credit. The primary aim of this legislation is to ease the financial burden on families, particularly those whose household members are Medicare beneficiaries. By incorporating these premiums into the calculation, the bill intends to provide a more equitable calculation for individuals when determining the tax credit they may receive for health care insurance.
Contention
Critics of HB7017 might raise concerns regarding the fiscal implications of amending the tax code in a way that accounts for additional premiums. This could lead to increased scrutiny over government spending and the allocation of tax credits. Moreover, some might argue that such amendments could complicate the tax filing process for families, particularly those already navigating the complex landscape of health care benefits and entitlements.
A bill to amend the Internal Revenue Code of 1986 to provide an advance refundable credit to offset certain flood insurance premiums, and for other purposes.
To amend the Internal Revenue Code of 1986 to provide a tax credit for expenses for household and elder care services necessary for gainful employment.
To amend the Internal Revenue Code of 1986 to provide a credit to small businesses for research activities related to the mitigation of certain drug threats.